Compositions and Methods For Treating Cancer With Anti-CD22 Immunotherapy
Technology
E-014-2018
Patent ID
E-014-2018-0-US-01
Country
US
Application Type
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
62/572,926
IC
NCI
Date Filed
Date Issued
Patent PDF